PRESS RELEASE published on 02/14/2025 at 12:28, 9 months 18 days ago Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates Moderna, Inc. reports Q4 revenues of $1.0B with a net loss of $(1.1)B. Forecasts 2025 revenue of $1.5-2.5B. Submitted 3 mRNA products for regulatory approval. Financial details and pipeline updates disclosed Revenues Net Loss Moderna MRNA Products 2025 Revenue
BRIEF published on 01/29/2025 at 13:05, 10 months 6 days ago Moderna to Announce Financial Results for Q4 and 2024 Financial Results Webcast Corporate Update MRNA Technology Moderna
PRESS RELEASE published on 01/29/2025 at 13:00, 10 months 6 days ago Moderna to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, February 14, 2025 Moderna, Inc. to host conference call on February 14, 2025 to report Q4 and full year 2024 financial results, and provide a corporate update. Details on webcast available on Moderna website Financial Results Conference Call Webcast Moderna Inc. MRNA Medicine
BRIEF published on 01/24/2025 at 12:35, 10 months 11 days ago Moderna Secures EU Tender for mRNA COVID-19 Vaccine Supply COVID-19 Moderna MRNA Vaccine Spikevax EU Tender
PRESS RELEASE published on 01/24/2025 at 12:30, 10 months 11 days ago Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union Moderna awarded tender to supply mRNA COVID-19 vaccine in EU, Norway, and North Macedonia, offering diverse formats like prefilled syringes. Enhancing vaccination campaigns with efficient options COVID-19 Moderna MRNA Vaccine Vaccination Campaigns Prefilled Syringes
BRIEF published on 01/17/2025 at 22:33, 10 months 18 days ago Moderna Advances mRNA-Based Influenza Vaccine Development Clinical Trials Moderna MRNA Vaccines BARDA Funding Influenza
PRESS RELEASE published on 01/17/2025 at 22:28, 10 months 18 days ago Moderna Announces Updates on Pandemic Influenza Program Moderna announces ongoing support from HHS to accelerate mRNA-based pandemic influenza vaccines development. Award received through BARDA-funded RRPV Consortium Moderna MRNA BARDA HHS Pandemic Influenza Vaccines
BRIEF published on 01/13/2025 at 13:05, 10 months 22 days ago Moderna Outlines Strategic Moves at J.P. Morgan Healthcare Conference Cost Reduction Plan Vaccine Approvals Moderna Financials 2025 Revenue Forecast Pipeline Milestones
PRESS RELEASE published on 01/13/2025 at 13:00, 10 months 22 days ago Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference Moderna, Inc. announces 2024 financial achievements and 2025 projections with emphasis on revenue growth, cost reductions, and pipeline milestones including COVID-19 and flu vaccines Revenue Growth Financial Updates Moderna Cost Reductions Pipeline Milestones
BRIEF published on 11/25/2024 at 13:05, 1 year ago Moderna to Present at December 2024 Investor Conferences Investor Conferences Healthcare Webcast MRNA Technology Moderna
Published on 12/05/2025 at 02:35, 6 hours 34 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 8 hours 9 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 4 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 9 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 08:30, 39 minutes ago Dahua Technology Celebrates Pro Challenge 2025 to Deepen Global Installer Ecosystem Collaboration
Published on 12/05/2025 at 08:30, 39 minutes ago Premier Miton Global Renewables Trust PLC - Suspension
Published on 12/05/2025 at 08:05, 1 hour 4 minutes ago Smartmi Unveils the Air Purifier 3: Powerful, Smart, and Stylish Air Care for Modern Homes
Published on 12/05/2025 at 08:01, 1 hour 8 minutes ago Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:01, 1 hour 8 minutes ago Custodian Property Income REIT plc: Interim results for the period ended 30 September 2025
Published on 12/05/2025 at 08:45, 24 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 15 hours 9 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 15 hours 24 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 15 hours 25 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 2 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health